Trial NCT04348006

View at ClinicalTrials.gov 
Org. Study IDs: AR200103
Secondary IDs: SEANM

Last trial update was posted on 2023-04-28

MeSH Interventions

Bortezomib Cyclophosphamide Dexamethasone Lenalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Newly Diagnosed Multiple Myeloma

Stopping Reasons

No patients were enrolled in the study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID